Saturday, July 4, 2026 Live from SEC EDGAR

The Wire Leaderboards Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

IPHA — Innate Pharma SA SEC Filings | FilingIndex

IPHANasdaq

Innate Pharma SA

Biological Products, (No Diagnostic Substances) · I0 · CIK 1598599

Develops innovative antibody-based therapeutics for cancer and other diseases

+ Watch View on EDGAR ↗

$169M

Market cap

$1.80

Last close

-0.6%

1D

+0.6%

5D

6K

Volume

Price$1.80-1.1%· 1Y

Jul 2L $1.17 · H $2.38Jul 2

278

Total filings

May 22, 2026

Last filing

12/31

Fiscal year end

All 6-K · 265 20-F · 7 424B5 · 3 424B4 · 1 SC 13G · 1 SC 13D · 1

20-F20-FApr 1, 2026 20-F20-FApr 30, 2025 20-F20-FApr 4, 2024 20-F20-FApr 6, 2023 20-F20-FApr 4, 2022 20-F

Similar companies

Comparable business profile · signals at a glance

TLXTelix Pharmaceuticals Ltd$4.0B+0.3%ONCBeOne Medicines Ltd.$30.9B+2.4%INSMINSMED Inc$24.2B+4.3%CTNMContineum Therapeutics, Inc.$564.5M-0.9%GYREGYRE THERAPEUTICS, INC.

20-F

Apr 27, 2021

20-FFORM 20-FApr 24, 2020

$818.3M

+12.6%

LGNDLIGAND PHARMACEUTICALS INC$6.4B+2.4%